Extended type 1 chain glycosphingolipids as tumor-associated antigens
US6083929A · kind A · utility
2Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 29, 1993 |
| Grant date | Jul 4, 2000 |
| Priority date | — |
| Expiry date | Dec 29, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/734
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A variety of compounds are provided which are usefdl as immunogens and as tumor markers. The present invention discloses methods relating to the detection of cancer. Extended forms of the lacto-series type 1 chain are shown to be present in various cancer tissues. The present invention also provides a cell line and the monoclonal antibody produced therefrom. Such an antibody has a number of uses, including in diagnostic or therapeutic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.